The invention relates to an isatin derivative and application thereof in preparation of medicines for resisting super-drug-resistance bacteria. The isatin derivative has very strong inhibitory action on MRSA (Methicillin-resistant Staphylococcus Aureus) and can be used for preparing novel effective anti-microbial medicines. The medicines can be made into injections, tablets, pills, capsules, suspending agents or emulsions. The administration routes of the medicines can be of oral administration and percutaneous, venous or intramuscular injection. The isatin derivative is as shown in the chemical structural formula (I), wherein in the formula, R1 is H, phenyl or p-fluorophenyl; R2 is F, C1, Br, I or H; R3 is F, C1, Br, I or H; R4 is H, CH3 and o-fluorobenzyl, m-fluorobenzyl and p-fluorobenzyl.